Hints and tips:
...America’s most famous investor, Warren Buffett, was circumspect of the US Spac boom, rightly suggesting back in 2021 that the incentive structure encouraged bad bets....
...“It is not at all clear that Merck is doing anything other than extending its monopoly power over the drug,” Warren said....
...“Pfizer and Moderna have already raked in billions [of dollars] in profits through the sales of their Covid-19 vaccines,” Warren told the Financial Times....
...The “windfall profits” drew fire from Elizabeth Warren, liberal Democratic senator, who called on the SEC to consider regulatory “reforms that would prevent abusive practices”....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...“We are ready to strike a deal with anyone,” he says, including progressive Democrats such as Elizabeth Warren, Bernie Sanders and Alexandria Ocasio-Cortez....
...It increased its stakes in AbbVie, Bristol-Myers Squibb and Merck, but sold out of Pfizer....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Warren Buffett’s Berkshire Hathaway placed a $5.7bn bet on four US pharmaceutical stocks in the third quarter, as the billionaire investor dumped holdings in several of the largest US banks....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...‘Perfect scenario’ Those look like V-shaped projections, Andrew Glenn thought to himself....
...Slovakia’s prime minister said he was ready to stand down to defuse a crisis over his decision to purchase Russia’s Sputnik V vaccine, which has not been approved by Europe’s regulator....
...That time Pfizer failed to clinch a deal for AstraZeneca If Ian Read had his way, AstraZeneca would be a unit of US pharma group Pfizer right now....
...Famed investor Warren Buffett has given up on the sector, selling his stakes in the four largest US carriers at a loss. “You’ve got too many planes,” he said....
...On the last Sunday of April 2019, a sleek Gulfstream V jet belonging to Occidental Petroleum touched down at Omaha airport....
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...Mr Greene has also worked on many complex M&A deals, including pharmaceutical company Mylan’s pending $50bn combination with Upjohn, a division of Pfizer....
...The six chief executives from Merck, Pfizer, AstraZeneca, AbbVie, Sanofi, and Bristol-Myers Squibb, plus an executive president from Johnson & Johnson, will face tough questions on Tuesday on what is fast...
...A decade ago, Jeffrey Kindler, then chief executive of US drugs giant Pfizer, was plotting an audacious $68bn acquisition of rival Wyeth....
...Pfizer shows how the adjustments made so far reflect the balance of different factors....
...Shares of large drugmakers also tumbled, as investors fretted they would struggle to maintain premium prices, with Pfizer, AbbVie and Merck losing between 1.6 per cent and 5.3 per cent....
...Warren Estey will leave his role as co-head of US equity capital markets to become the bank’s head of Americas natural resources....
...(FT) Japan Inc goes global for M&A advice Only three domestic brokerages rank among the top-ten deal advisers in Japan during the third quarter. Why is Japan Inc looking for foreign advice?...
...Warren Buffett is a new investor. Apple has not been the only technology company setting records this year. The sector now accounts for five of the most valuable companies within the S&P 500....
International Edition